LFMD · LifeMD, Inc.
$4.32
+0.17 (+4.10%)
At close · Jul 20
Market Cap
$208.93M
Shares
48.36M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$194.06M
-8.7%
FY2025
Net Income
$14.35M
+176%
FY2025
Gross Margin
85.72%
-3pp
FY2025
Operating Margin
-3.95%
+3.6pp
FY2025
Diluted EPS
$0.25
FY2025
Operating Cash Flow
$8.28M
-52.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $220M – $230M | $192.88M | $194.06M | $212.45M | $152.55M | $119.03M | $92.88M | $37.29M | $12.47M | $8.32M | $5.05M | $5.24M | $1.22M | $714.16K | $808.36K | |
| — | $25.5M | $27.71M | $24.07M | $18.9M | $18.67M | $18M | $8.91M | $3.27M | $1.97M | $1.48M | $1.95M | $247.77K | $172.85K | $181.3K | |
| — | $167.37M | $166.34M | $188.39M | $133.65M | $100.37M | $74.88M | $28.39M | $9.2M | $6.36M | $3.57M | $3.29M | $971.09K | $541.31K | $627.06K | |
| — | — | 85.72% | 88.67% | 87.61% | 84.32% | 80.62% | 76.12% | 73.77% | 76.35% | 70.65% | 62.85% | 79.67% | 75.8% | 77.57% | |
| — | — | — | — | — | — | — | — | — | — | — | $23.93K | $23.93K | — | — | |
| — | $93.68M | $86.07M | $103.02M | $76.45M | $78.37M | $82.54M | $41.67M | $8.17M | — | — | — | — | — | — | |
| — | $58.77M | $57.94M | $72.66M | $51.69M | $46.96M | $39.57M | $42.21M | $2.4M | $1.1M | $851.26K | $1.03M | $331.41K | $373.67K | $393.44K | |
| — | $119.25K | $94K | $982.41K | $971.46K | $926.54K | $342.31K | $335.61K | $335.61K | $195.78K | — | — | — | — | — | |
| — | $183.24M | $174.01M | $204.53M | $148.14M | $143.81M | $129.18M | $86.21M | $12.09M | $8.41M | $4.64M | $4.47M | — | — | — | |
| — | -$15.87M | -$7.67M | -$16.14M | -$14.49M | -$43.45M | -$54.3M | -$57.82M | -$2.89M | -$2.06M | -$1.07M | -$1.17M | -$262.22K | -$530.88K | -$546.41K | |
| — | — | -3.95% | -7.6% | -9.5% | -36.5% | -58.47% | -155.04% | -23.18% | -24.7% | -21.12% | -22.42% | -21.51% | -74.34% | -67.59% | |
| — | $840.85K | $1.36M | $2.18M | $2.6M | $1.28M | $3.02M | $1.67M | $761.15K | $354.39K | $100.52K | $48.61K | $37.48K | $4683 | $3385 | |
| — | -$3.95M | — | — | — | — | — | -$2.58M | — | $502.83K | -$1.22M | -$1.22M | — | — | — | |
| — | — | -$10.19M | -$18.33M | -$17.41M | -$44.66M | -$61.32M | -$60.4M | -$3.65M | -$1.48M | — | -$1.22M | -$172.43K | -$477.69K | -$285.46K | |
| — | — | $45.72K | $402K | $428K | $360.7K | $7700 | $122.5K | -$122.5K | -$124.7K | — | — | — | — | — | |
| — | $5.21M | $14.35M | -$18.88M | -$20.6M | -$45.54M | -$60.9M | -$58.65M | -$3.14M | -$1.24M | -$1.21M | -$1.11M | -$61.99K | -$460.49K | -$268.26K | |
| — | — | 7.4% | -8.89% | -13.5% | -38.25% | -65.57% | -157.26% | -25.16% | -14.91% | -23.86% | -21.14% | -5.09% | -64.48% | -33.19% | |
| — | — | $1.27M | $153.23K | $2.76M | $514.63K | -$426.35K | -$1.88M | -$391.06K | -$119.26K | -$12.49K | -$115.75K | -$97.24K | — | — | |
| — | $2.1M | $11.25M | -$21.99M | -$23.7M | -$48.64M | -$61.77M | -$63.36M | — | — | — | — | — | — | — | |
| USD/shares | — | — | $0.25 | — | — | — | — | — | — | — | -$0.15 | — | — | — | — |
| USD/shares | — | — | $0.25 | — | — | — | — | — | — | — | -$0.15 | — | — | — | — |
| shares | — | — | 45.13M | 41.2M | 33.91M | 30.98M | 27.01M | 14.28M | 9.9M | 8.84M | 8.35M | 6.7M | 6.16M | 6.07M | 5.88M |
| shares | — | — | 45.13M | 41.2M | 33.91M | 30.98M | 27.01M | 14.28M | 9.9M | 8.84M | 8.35M | 6.7M | 6.16M | 6.07M | 5.88M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $346.65K in buybacks, $13.31M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.34×
EV/EBIT
—
Health Information Services median 26.13×
P/E (TTM)
—
Health Information Services median 32.97×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Telehealth Subscription Revenue | $113,269,103 | $67,684,547 | $4,266,255 | — | — | — |
| Telehealth | $80,786,095 | $82,139,528 | $88,886,664 | $82,649,845 | $68,197,128 | $30,561,163 |
| Medifast Collaboration Revenue | — | $5,000,000 | $5,000,000 | — | — | — |
| Worksimpli | — | — | — | — | — | $6,732,747 |
| WorkSimpli | — | $14,900,000 | $14,000,000 | $36,383,675 | $24,678,678 | — |
By Product & Service (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Telehealth Revenue | $154,824,075 | $98,152,919 | $82,649,845 | $68,197,128 | — |
| Telehealth | — | — | — | — | $30,561,163 |
| Worksimpli | — | — | — | — | $6,732,747 |
| WorkSimpli Revenue | — | $54,394,087 | $36,383,675 | $24,678,678 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Telehealth | -$7,669,694 | -$20,401,988 | -$25,261,021 | -$45,918,588 | -$51,411,142 | -$55,698,251 |
| Worksimpli | — | — | — | — | — | -$2,121,202 |
| WorkSimpli | — | — | $10,771,748 | $2,470,807 | -$2,889,939 | — |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Telehealth | -9.5% | -24.8% | -28.4% | -55.6% | -75.4% | -182.3% |
| Worksimpli | — | — | — | — | — | -31.5% |
| WorkSimpli | — | — | 76.9% | 6.8% | -11.7% | — |
Key facts
CIK
948320
CUSIP
53216B104
13F (30d)
11 filings
11 filers
Visit website
Investor relations